Weight loss treatments have evolved rapidly in recent years, offering new hope for people seeking effective and convenient options. Eli Lilly’s newly FDA-approved oral tablet, Foundayo (orforglipron), joins this growing field as an alternative to injectable medications like Mounjaro and Wegovy, and in direct competition with Novo Nordisk's current offering of oral semaglutide (OZempic/Wegovy), which is available in the UK as Rybelsus. Foundayo oral tablet close-up What is Foundayo and How...

Results of Retatrutide show promising outcomes for those wanting to loose weight and control their Type 2 diabetes...

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with semaglutide (Ozempic, Rybelsus & Wegovy)